Bulk of Bone Biopsy Systems Demand Stimulated by Cancer Detection Screenings
25 Mar 2021
Collaborate
High burden of orthopedic cancers is stimulating enhanced biopsy systems deployment to enable timely treatment
Fact.MR, Rockville MD: The global bone biopsy systems market study being conducted by market research firm Fact.MR projects a positive expansion outlook for 2021 and beyond. As the coronavirus pandemic’s onslaught recedes, hospitals and clinics are reverting to their pre-pandemic routine, leading to a resumption in bone biopsy procedures, thus restoring demand.
As the global geriatric population exponentially surges, prevalence of osteoporosis and low bone mass has risen to 52 million by 2010, and reached 51 million active cases by 2020. This means that over half of all Americans aged above 50 years are at an elevated risk of developing osteoporosis of the hip. According to the World Health Organization, approximately 1.71 billion have musculoskeletal conditions worldwide. Amid such a scenario, demand for advanced bone biopsy procedures is becoming the need of the hour.
According to Fact.MR’s study, growth in the bone biopsy systems market is underpinned by rising prevalence of bone related disorders, which is facilitating enhanced research and development to introduce technologically advanced and precise therapeutics. Since the beginning of the previous decade, breakthroughs such as intraosseous medicine is ushering in a much-needed change in bone diagnostics, especially in bone marrow procedures.
“With increased prevalence of sedentary living, chronic bone disorders are only set to incline, prompting patients to seek effective treatment. This is providing immense opportunities for prominent bone biopsy manufacturers to tap lucrative markets, especially in the developing world,” remarks the Fact.MR analyst.
For more insights into the Market, Request a Sample of this Report
Key Takeaways from Fact.MR’s Bone Biopsy Systems Study
By type, needle biopsy is expected to remain most prominent, given the rising demand for precise surgeries
Cancer detection constitutes the primary indication purpose behind deploying bone biopsy systems
By end-user, hospitals to represent the largest clientele for bone biopsy systems
US to remain a promising market, attributed to rising incidence of arthritis and osteoarthritis
Treatment for secondary bone cancer to stimulate enhanced bone biopsy systems adoption in the UK
Rising osteoporosis cases is fueling bone biopsy treatment across Germany and France
India & China to attract huge investments, attributed to increased vulnerability to joint fractures among adults in urban areas
Bone Biopsy Market- Prominent Drivers
Growing incidence of bone related cancers is stimulating demand for advanced bone biopsy systems
Emergence of multiple detection approaches, including those involving advanced imaging techniques, is driving increased sales
Rising international level collaborations to facilitate enhanced bone disorders research is providing a wide ground for key bone biopsy systems manufacturers
Bone Biopsy Market- Key Restraints
Asymmetrical healthcare infrastructure in developing countries is restricting uptake of bone biopsy systems amid financial constraints
Limited awareness concerning effective bone disorders diagnosis among patients leads to reduced screening procedures, limiting sales
Discover more about the bone biopsy systems market with figures, data tables and the table of contents. You will also find detailed market segmentation on
Competitive Landscape
Merit Medical Systems, Stryker Corporation, Argon Medical Devices Inc., Becton Dickinson & Company, Teleflex Incorporated, Laurane Medical, Mermaid Medical A/S and Remington Medical are some prominent bone biopsy systems manufacturers profiled in Fact.MR’s study. Offering the latest biopsy equipment remains the core strategy of most of the aforementioned market players.
Merit Medical Systems is a pioneer in the bone biopsy domain, offering a wide range of biopsy systems. Some of its products include the HuntingtonTM Bone Biopsy System, KensingtonTM Bone Biopsy System, MadisonTM Bone Biopsy System, and the WestbrookTM Bone Biopsy System among others. Additionally, it also offers the PrestonTM Bone Biopsy Accessories and BiopSafe® Biopsy Sample Systems respectively.
Likewise, Stryker Corporation offers an entire range of bone biopsy kits which are compatible with their 8, 10 and 11 gauge needles. The coaxial design allows for biopsy collection of a core sample within the vertebral body. The needle’s syringe measures 3cc and features a rotating handle for greater flexibility.
More Insights on the Bone Biopsy Systems Market
In its latest report, Fact.MR offers unbiased analysis of the global bone biopsy systems market. In order to understand the global market potential, its growth, and scope, the market is segmented on the basis of type (needle biopsy and open biopsy), indication (cancer, bone infection, osteoporosis, chronic kidney disease and others) and end user (hospitals, specialty clinics, and ambulatory surgical centers) across seven regions (North America, Latin America, Western Europe, Eastern Europe, Japan, APEJ and Middle East & Africa)
Request for No-Obligation Table of Content
Explore Fact.MR’s Coverage on the Healthcare Domain
Pleural Catheters Market: Fact.MR’s extensive coverage on the pleural catheters market provides detailed assessment on the key market dynamics, including drivers, trends, and opportunities expected to present themselves throughout the course of the market’s expansion trajectory. Key indicators of market growth, which include Year-on-Year (Y-o-Y) growth of the market, and compound annual growth rate (CAGR) are explained in Fact MR’s study in a comprehensive manner.
Dyslipidemia Therapeutics Market: The global dyslipidemia therapeutics market research report compiled by Fact.MR elaborates on the key expansion dynamics anticipated to play a role in its future growth. Market statistics have been presented across key segments spread over prominent geographies while also incorporating an in-depth competition landscape analysis to provide an unbiased and realistic market growth picture.
Lewy Body Dementia Market: The Fact.MR report on Lewy body dementia treatment market provides an exhaustive analysis of the Lewy body dementia treatment market roadmap for the upcoming decade. The report on Lewy body dementia treatment market also offers a comprehensive segmental analysis, wherein all the lucrative segments are given in detail in tandem with their performance during the assessment period.
About Fact.MR
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.
Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E: sales@factmr.com
Follow Us: LinkedIn | Twitter
Market Intelligence Services: Marketngage
Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Source: Fact.MR
Organizations
Indications
Targets
-Drugs
-Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.